Release behavior, kinetic and antimicrobial study of nalidixic acid from [Zn2(bdc)2(dabco)] metal-organic frameworks
In the present study, a hydrothermal method was developed to prepare nalidixic acid-loaded [Zn2(bdc)2(dabco)] metal–organic frameworks. The self-assembly of primary building blocks was used for synthesis of [Zn2(bdc)2(dabco)] at room temperature. The zinc metal ion was used as a connector, 1,4-benzenedicarboxylate (bdc) as a chelating ligand, and 1,4-diazabicyclo[2.2.2]octane (dabco) as a bridging ligand. The metal organic frameworks were used as the carriers for drug delivery system, where it could entrap nalidixic acid as a model drug. X-ray powder diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), ultraviolet-visible spectroscopy (UV–vis), BET nitrogen adsorption–desorption method, and scanning electron microscopy (SEM) were used for characterization of samples. The drug release was also monitored, and 96 and 62% of the loaded drug were released over 120 h at pH values of 5.0 and 7.4, respectively. The antimicrobial activities of [Zn2(bdc)2(dabco)] and nalidixic acid-loaded [Zn2(bdc)2(dabco)] were tested against Gram-positive and Gram-negative species. The results revealed that this nanoscale metal organic framework may be regarded as a simple and stable platform for drug release in the treatment of infectious diseases.
Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.
Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.